Barasertib (AZD1152-HQPA),Aurora B激酶抑制剂

Barasertib (AZD1152-HQPA) (订货以英文为准)

编号:A127799
CAS号:722544-51-6
分子式:C26H30FN7O3
分子量:507.56
货号 品牌 包装 目录价 您的价格 库存 数量 购买
A127799-250mg 阿拉丁 250mg ¥2699.90
A127799-10mg 阿拉丁 10mg ¥219.90
A127799-50mg 阿拉丁 50mg ¥769.90
产品名称 Barasertib (AZD1152-HQPA)
中文名称 Barasertib (AZD1152-HQPA),Aurora B激酶抑制剂
CAS号 722544-51-6
MDL编码 MFCD10687152
分子式(M.F.) C26H30FN7O3
分子量(M.W.) 507.56
储存条件 -20°C储存
沸点796.7° C at 760 mmHg
折光率1.68
溶解性DMSO ≥100mg/mL Water ≥100mg/mL Ethanol ≥2.8mg/mL
存贮条件储存温度-20°C
应用A highly selective ARK-2 inhibitor
产品介绍AZD1152-HQPA是AZD-1152的活性代谢物,AZD1152-HQPA (Barasertib)是Aurora B 高选择性抑制剂,IC50为0.37 nM,比对Aurora A的抑制性高100倍。
备注AZD1152-HQPA (Barasertib) is a highly selective Aurora B inhibitor with IC50 of 0.37 nM, ~100 fold more selective for Aurora B over Aurora A.
生化机理AZD1152-HQPA is the active metabolite of AZD-1152, a potent selective Aurora Kinase B inhibitor. AZD1152 is 50-fold selective for Aurora kinase B over Aurora kinase C and over 1000-fold selective for Aurora kinase B over Aurora Kinase A. (IC50s: aurora-A, 1,369 nmol/L; aurora-B, 0.36 nmol/L; aurora-C, 17.0 nmol/L). It is converted in plasma to the active form AZD1152-HQPA, which has been shown to have antineoplastic activity in a variety of animal models and human cancer cell lines.
别名AZD1152; AZD 1152; 5-((7-(3-(乙基(2-羟基乙基)氨基)丙氧基)-4-喹唑啉)氨基)-N-(3-氟苯基)-1H-吡唑-3-乙酰胺;;Barasertib;5-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)-4-quinazolinyl)amino)-n-(3-fluorophenyl)-1h-pyrazole-3-acetamide;3-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-5-acetamide
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:2098-66-0
¥ 3545.00 C829982-100mg
¥ 200.00 100566-100g
CAS号:87-66-1
¥ 26.00 P-98650+25g-25g
CAS号:53784-84-2
¥ 748.80 X170299A-100mg
CAS号:747-36-4
¥ 100.00 B28598-20mg
CAS号:29667-48-9
¥ 2136.90 M633548-100mg
CAS号:1380005-74-2
¥ 1468.80 X192029A-100mg
CAS号:61349-72-2
¥ 1995.00 1958347-100mg